MP-SAT作为支原体肺炎患儿疗效监测指标的可行性分析

doi:10.3969/j.issn.1000-8535.2021.01.017

摘要/Abstract

摘要： 目的分析肺炎支原体RNA实时荧光恒温扩增技术(MP-SAT)作为肺炎支原体肺炎(MPP)患儿疗效监测指标的可行性。方法选择2017年10月—2018年10月我院儿科收治的因CAP住院的患儿178例为研究对象,其中MPP组80例,非MPP组98例,分别检测血清MP抗体(MP-Ab)和咽拭子MP-RNA,对两种方法检测结果进行统计学分析,以MP-Ab检测为诊断MPP的参照试验,分析MP-SAT诊断MPP的准确性,对MP-SAT和MP-Ab均阳性的MPP病例行动态观察,比较MP-SAT和MP-Ab在患儿不同治疗时间点的检出率,分析MP-SAT转阴时间与临床痊愈时间的相关性,分析MP-SAT转阴时间与MPP患儿临床症状、实验室指标及X线胸片的相关性。结果 MP-SAT和MP-Ab结果不一致的比例在MPP组和非MPP组分别为60.00% (48/80)和19.39%(19/98);MP-SAT、MP-Ab在特异性和阳性预测值方面,差异有统计学意义(P＜0.05);MP-SAT、MP-Ab在敏感度和阴性预测值方面,差异无统计学意义(P＞0.05);MP-SAT、MP-Ab均为阳性28例(35.00%),MP-SAT阳性检出率随治疗时间的延长降低(P＜0.05),MP-Ab阳性检出率随治疗时间的延长升高(P＜0.05);28例临床痊愈时间为(3.11±0.88)周,MP-SAT转阴时间为(3.25±0.74)周,差异无统计学意义(P＞0.05);MP-SAT转阴时间越长的病例表现为发热持续时间越长,X线胸片肺大片实变比例越高,CRP水平越高,LDH水平越高,中性粒细胞百分比越高,淋巴细胞百分比越低(P＜0.05)。结论 MP-SAT作为新一代RNA活菌检测技术在支原体肺炎患儿疗效监测中有较高的价值,值得推广。

关键词: MP-SAT, 肺炎支原体肺炎, 疗效监测, 可行性

Abstract: Objective To investigate the feasibility of Mycoplasma pneumoniae-simultaneous amplification and testing (MP-SAT)as a monitoring index for children with Mycoplasma pneumoniae pneumonia (MPP). Methods 178 hospitalized children with community-acquired pneumonia (CAP)in our hospital from October 2017 to October 2018 were selected and divided into two groups, namely MPP group (n=80)and non-MPP group (n=98). Serum MP antibody (MP-Ab)and throat swab MP-RNA were detected separately. The MP-Ab test was used as a reference for the analysis of accuracy of MP-SAT for MPP diagnosis. The MPP patients with positive MP-SAT and positive MP-Ab were observed dynamically. The detection rates of MP-SAT and MP-Ab in different treatment time points were compared. The correlation of MP-SAT negative time with clinical recovery time, clinical symptoms, laboratory parameters and chest X-ray was analyzed. Results The ratio of inconsistent MP-SAT and MP-Ab results was 60.00% (48/80)and 19.39% (19/98)in the MPP group and the non-MPP group, respectively. The MP-SAT and MP-Ab were statistically different in terms of specificity and positive predictive value (P<0.05), while no difference was found in the sensitivity and negative predictive value (P>0.05). Both MP-SAT and MP-Ab were positive in 28 cases (35.00%). The positive rate of MP-SAT was decreased with the prolongation of treatment time (P<0.05), meanwhile the positive rate of MP-Ab was increased with the treatment time (P<0.05); the clinical recovery time of 28 cases was (3.11±0.88)weeks, and the MP-SAT negative time was (3.25±0.74)weeks, with no statistical difference (P>0.05). The long-term duration of MP-SAT was characterized by long duration of fever, high consolidation rate of X-ray chest radiograph, high CRP level, high LDH level, high percentage of neutrophils, and low percentage of lymphocytes (P<0.05). Conclusion MP-SAT, as a new generation of RNA live bacteria detection technology, has high value in monitoring the efficacy of Mycoplasma pneumonia in children, and it is worth promoting.

Key words: MP-SAT, MPP, Therapeutic effect, Feasibility

司徒宝珠. MP-SAT作为支原体肺炎患儿疗效监测指标的可行性分析[J]. 广州医药, 2021, 52(1): 87-91.

SI-TU Baozhu. Feasibility analysis of MP-SAT as a monitoring index for children with Mycoplasma pneumoniae pneumonia[J]. Guangzhou Medical Journal, 2021, 52(1): 87-91.

参考文献

[1] 刘云琴, 张燕, 张智玲. 布地奈德混悬剂雾化吸入佐治小儿支原体肺炎临床观察[J]. 新疆医学, 2017,5(11):123-125.
[2] 丁霞, 冉丹丹, 周闯. 血清降钙素原、白介素-6在肺炎支原体混合细菌感染早期诊断中的价值[J]. 新疆医学, 2018,48(11):88-90.
[3] 薛峰, 李梅. 肺炎支原体感染应用孟鲁司特治疗的效果[J]. 新疆医学, 2016,46(1):87-88.
[4] 郭丽,孙琳,郭琰,等. 肺炎支原体RNA检测在儿童肺炎支原体肺炎疗效监测中的应用价值[J]. 中国循证儿科杂志, 2016, 11(2):109-112.
[5] GUO L,SUN L,GUO Y, et al. Clinical value of Mycoplasma pneumoniae RNA detection in the monitoring of Mycoplasma pneumoniae pneumonia treatment in children[J]. Chin J Evid Based Pediatr, 2016,11(2):109-112.
[6] WANG L, FENG Z, ZHAO M, et al. A comparison study between GeXP-based multiplex-PCR and serology assay for Mycoplasma pneumoniae detection in children with community acquired pneumonia[J]. BMC Infect Dis, 2017, 17(1):518.
[7] 余丽丽, 赵德育. 肺炎支原体肺炎发病机制研究进展[J]. 中国实用儿科杂志, 2017, 32(3):234-238.
[8] 李晓品, 李艳红, 许凤勤, 等. 阿奇霉素对肺炎支原体肺炎感染患儿Th1/Th2指标的影响研究[J]. 中华医院感染学杂志, 2016, 26(16):3797-3799.
[9] 周成, 王书举, 翟玉峰, 等. 布地奈德雾化吸入对支原体肺炎患儿炎症因子与免疫功能的影响[J]. 中华医院感染学杂志, 2016, 26(9):2136-2138.
[10] 王娟, 孙军, 高长龙, 等. 纤维支气管镜肺泡灌洗术治疗儿童难治性支原体肺炎疗效分析[J]. 临床儿科杂志, 2017, 35(1):16-18.
[11] 冯雪莉,李勤静,徐保平,等. RNA恒温扩增检测技术在儿童肺炎支原体肺炎中的诊断价值评估[J]. 中华实用儿科临床杂志, 2016, 31(16):1222-1226.
[12] 林苗苗, 施李芬, 余坚,等. 肺炎支原体RNA和DNA检测技术对儿童肺炎支原体肺炎诊断的价值[J]. 中国妇幼保健, 2018,33(5):99-101.
[13] LI W, FANG Y H, SHEN H Q, et al. Evaluation of a real-time method of simultaneous amplification and testing in diagnosis of Mycoplasma pneumoniae infection in children with pneumonia[J]. Plos One, 2017, 12(5):e0177842.
[14] DING Y, LEI X L, SUN D, et al. Expression and verification of miRNAs in peripheral blood of Mycoplasma pneumoniae pneumonia[J]. J Clin Pediatr, 2017,35(2):90-93.
[15] WEI H, XU X, LEI Y, et al. The role of the PM 2.5-associated metals in pathogenesis of child Mycoplasma Pneumoniae, infections: a systematic review[J]. Environ Sci Pollution Res, 2016, 23(11):10604-10614.